Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Viemed Healthcare (VMD) over the last 7 years, with Q3 2025 value amounting to $19.6 million.

  • Viemed Healthcare's Non-Current Debt rose 43657.53% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 43657.53%. This contributed to the annual value of $3.6 million for FY2024, which is 4020.33% down from last year.
  • Viemed Healthcare's Non-Current Debt amounted to $19.6 million in Q3 2025, which was up 43657.53% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Non-Current Debt ranged from a high of $19.6 million in Q3 2025 and a low of $3.5 million during Q2 2025
  • Moreover, its 5-year median value for Non-Current Debt was $4.3 million (2021), whereas its average is $6.2 million.
  • The largest annual percentage gain for Viemed Healthcare's Non-Current Debt in the last 5 years was 43657.53% (2025), contrasted with its biggest fall of 6024.1% (2025).
  • Over the past 5 years, Viemed Healthcare's Non-Current Debt (Quarter) stood at $4.3 million in 2021, then decreased by 3.48% to $4.2 million in 2022, then soared by 44.42% to $6.0 million in 2023, then tumbled by 40.2% to $3.6 million in 2024, then soared by 445.7% to $19.6 million in 2025.
  • Its last three reported values are $19.6 million in Q3 2025, $3.5 million for Q2 2025, and $3.5 million during Q1 2025.